Development of Peptide Vaccines in Dengue.

Abstract:

:Dengue is one of the most important arboviral infections worldwide, infecting up to 390 million people and causing 25,000 deaths annually. Although a licensed dengue vaccine is available, it is not efficacious against dengue serotypes that infect people living in South East Asia, where dengue is an endemic disease. Hence, there is an urgent need to develop an efficient dengue vaccine for this region. Data from different clinical trials indicate that a successful dengue vaccine must elicit both neutralizing antibodies and cell mediated immunity. This can be achieved by designing a multi-epitope peptide vaccine comprising B, CD8+ and CD4+ T cell epitopes. As recognition of T cell epitopes are restricted by human leukocyte antigens (HLA), T cell epitopes which are able to recognize several major HLAs will be preferentially included in the vaccine design. While peptide vaccines are safe, biocompatible and cost-effective, it is poorly immunogenic. Strategies to improve its immunogenicity by the use of long peptides, adjuvants and nanoparticle delivery mechanisms are discussed.

journal_name

Curr Pharm Des

authors

Reginald K,Chan Y,Plebanski M,Poh CL

doi

10.2174/1381612823666170913163904

subject

Has Abstract

pub_date

2018-01-01 00:00:00

pages

1157-1173

issue

11

eissn

1381-6128

issn

1873-4286

pii

CPD-EPUB-85764

journal_volume

24

pub_type

杂志文章,评审
  • Expression of P-gp in Glioblastoma: What we can Learn from Brain Development.

    abstract::P-Glycoprotein (P-gp) is a 170-kDa transmembrane glycoprotein that works as an efflux pump and confers multidrug resistance (MDR) in normal tissues and tumors, including nervous tissues and brain tumors. In the developing telencephalon, the endothelial expression of P-gp, and the subcellular localization of the transp...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/1381612826666200318130625

    authors: de Trizio I,Errede M,d'Amati A,Girolamo F,Virgintino D

    更新日期:2020-01-01 00:00:00

  • New therapies in cystic fibrosis.

    abstract::Cystic fibrosis is caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene that lead to abnormalities in transepithelial ion transport in the airways of affected patients. Lung disease is the major contributor to morbidity and mortality in patients with cystic fibrosis but recommende...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161212799315984

    authors: Ratjen F,Grasemann H

    更新日期:2012-01-01 00:00:00

  • Difficulties in describing allergic disease modulation by pre-, pro- and synbiotics.

    abstract::The so-called hygiene hypothesis is, at least in part, accountable for the increase in allergic diseases in the developed countries. Although there is support for one of its primary predictions that host-microbe interactions in early life have longterm effects on the development of disease across populations, the theo...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161212800166031

    authors: Jeurink PV,Rijnierse A,Martin R,Garssen J,Knippels LM

    更新日期:2012-01-01 00:00:00

  • Beta 3-adrenoceptor agonists as anti-diabetic and anti-obesity drugs in humans.

    abstract::In the early 1980s, an "atypical" beta-adrenergic receptor was discovered and subsequently called the beta (3)-adrenoceptor (beta(3)-AR). Agonists of the beta(3)-AR were observed to simultaneously increase lipolysis, fat oxidation, energy expenditure and insulin action leading to the belief that this receptor might se...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612013397339

    authors: de Souza CJ,Burkey BF

    更新日期:2001-09-01 00:00:00

  • Bioactivity Prediction Based on Matched Molecular Pair and Matched Molecular Series Methods.

    abstract:BACKGROUND:Enhancing a compound's biological activity is the central task for lead optimization in small molecules drug discovery. However, it is laborious to perform many iterative rounds of compound synthesis and bioactivity tests. To address the issue, it is highly demanding to develop high quality in silico bioacti...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/1381612826666200427111309

    authors: Ding X,Cui C,Wang D,Zhao J,Zheng M,Luo X,Jiang H,Chen K

    更新日期:2020-01-01 00:00:00

  • Inhibitors of tryptase for the treatment of mast cell-mediated diseases.

    abstract::Human tryptase is a structurally unique and mast cell specific trypsin-like serine protease. Recent biological and immunological investigations have implicated tryptase as a mediator in the pathology of numerous allergic and inflammatory conditions including rhinitis, conjunctivitis, and most notably asthma. A growing...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:

    authors: Rice KD,Tanaka RD,Katz BA,Numerof RP,Moore WR

    更新日期:1998-10-01 00:00:00

  • Potential novel anxiolytic drugs.

    abstract::Anxiety disorders are common and disabling conditions. Current drug treatment methods have limitations including resistance, delayed efficacy and side effects. The advent of sophisticated imaging techniques and the production of highly selective receptor ligands have increased our knowledge of the biological mechanism...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161208786848775

    authors: Christmas D,Hood S,Nutt D

    更新日期:2008-01-01 00:00:00

  • Early life and oxidative stress in psychiatric disorders: what can we learn from animal models?

    abstract::Schizophrenia is a complex pathology characterized by the occurrence of a variety of symptoms classified as positive, negative and cognitive. Although the exact etiopathogenesis of this disorder has not been unraveled yet, many theories have been endorsed during the last years. Among these, the neurochemical theories ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612821666150105122422

    authors: Mhillaj E,Morgese MG,Trabace L

    更新日期:2015-01-01 00:00:00

  • Intestinal Dysbiosis, Gut Hyperpermeability and Bacterial Translocation: Missing Links Between Depression, Obesity and Type 2 Diabetes.

    abstract::The comorbid prevalence of major depressive disorder (MDD) with obesity and type II diabetes mellitus reflects the existence of a subset of individuals with a complex common pathophysiology and overlapping risk factors. Such comorbid disease presentations imply a number of difficulties, including: decreased treatment ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612822666160922165706

    authors: Slyepchenko A,Maes M,Machado-Vieira R,Anderson G,Solmi M,Sanz Y,Berk M,Köhler CA,Carvalho AF

    更新日期:2016-01-01 00:00:00

  • Recent Updates in the Computer Aided Drug Design Strategies for the Discovery of Agonists and Antagonists of Adenosine Receptors.

    abstract:: ...

    journal_title:Current pharmaceutical design

    pub_type: 社论

    doi:10.2174/1381612825999190515120510

    authors: Deb PK

    更新日期:2019-01-01 00:00:00

  • The impact of traditional plants and their secondary metabolites in the discovery of COVID-19 treatment.

    abstract:BACKGROUND:Coronavirus Disease-2019 belongs to the family of viruses which cause a serious pneumonia along with fever, breathing issues and infection of lungs for the first time in China and later spread worldwide. OBJECTIVE:Several studies and clinical trials have been conducted to identify potential drugs and vaccin...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章

    doi:10.2174/1381612826666201118103416

    authors: Bibi S,Sarfraz A,Mustafa G,Ahmed Z,Zeb MA,Wang YB,Khan T,Khan MS,Kamal MA,Yu H

    更新日期:2020-11-17 00:00:00

  • Imaging beta-amyloid plaques and neurofibrillary tangles in the aging human brain.

    abstract::The development of radioligands to image beta-amyloid (A beta) plaques and neurofibrillary tangles (NFTs) in vivo in the aging human brain is an important and active area of radiopharmaceutical design. When used in combination with positron emission tomography (Pet) or single photon emission computed tomography (spect...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612043384772

    authors: Mathis CA,Wang Y,Klunk WE

    更新日期:2004-01-01 00:00:00

  • Hypersensitivity reactions to neuromuscular blocking agents.

    abstract::Neuromuscular blocking agents are the leading drugs responsible for immediate hypersensitivity reactions during anaesthesia. Most hypersensitivity reactions represent IgE-mediated allergic reactions. Their incidence is estimated to be between 1 in 3,000 to 1 in 110,000 general anaesthetics. However striking variations...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161208786369704

    authors: Mertes PM,Aimone-Gastin I,Guéant-Rodriguez RM,Mouton-Faivre C,Audibert G,O'Brien J,Frendt D,Brezeanu M,Bouaziz H,Guéant JL

    更新日期:2008-01-01 00:00:00

  • Phosphodiesterase type 5 inhibitors: molecular pharmacology and interactions with other phosphodiesterases.

    abstract::Erectile function is determined by tight regulation of relaxation or contraction of corpus cavernosal smooth muscle, which is the result of a long and complex chain of molecular events. Control of erectile function resides in signaling pathways of the central and peripheral nervous system, as well as intracellular eve...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161205774913426

    authors: Seftel AD

    更新日期:2005-01-01 00:00:00

  • Therapeutic Potential of Targeting TREM-1 in Inflammatory Diseases and Cancer.

    abstract::The triggering receptor expressed on myeloid cells (TREM)-1 is a member of the Ig-like immunoregulatory receptor family and a major amplifier of innate immune responses. TREM- 1 has been implicated in the development and perpetuation of a number of inflammatory disorders, and soluble TREM-1 levels are a clinically val...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612822666160826110539

    authors: Bosco MC,Raggi F,Varesio L

    更新日期:2016-01-01 00:00:00

  • Design of multivalent ligand targeting G-protein-coupled receptors.

    abstract::More and more evidences are still accumulating rapidly on the G-protein-coupled-receptors (GPCRs) dimerization/oligomerization. Such common feature of GPCRs has called extensive attention to both pharmacologists and medicinal chemists for illustration of the pharmacological functions and therapeutic utilities of such ...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161209787315639

    authors: Liu Z,Zhang J,Zhang A

    更新日期:2009-01-01 00:00:00

  • An update on adenosine A2A-dopamine D2 receptor interactions: implications for the function of G protein-coupled receptors.

    abstract::Adenosine A(2A)-dopamine D(2) receptor interactions play a very important role in striatal function. A(2A)-D(2) receptor interactions provide an example of the capabilities of information processing by just two different G protein-coupled receptors. Thus, there is evidence for the coexistence of two reciprocal antagon...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161208784480108

    authors: Ferré S,Quiroz C,Woods AS,Cunha R,Popoli P,Ciruela F,Lluis C,Franco R,Azdad K,Schiffmann SN

    更新日期:2008-01-01 00:00:00

  • Vesicular carriers for skin drug delivery: the Pheroid™ technology.

    abstract::The skin remains an attractive area for drug delivery. The skin, however, often limits the ingress of drugs, because of its very low permeability. Much research, focusing on employing a variety of physical and chemical methods, aimed at reversibly altering skin permeability in favour of compounds, has been reported. O...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612821666150428125812

    authors: Kilian D,Shahzad Y,Fox L,Gerber M,Du Plessis J

    更新日期:2015-01-01 00:00:00

  • Resveratrol and clinical trials: the crossroad from in vitro studies to human evidence.

    abstract::Resveratrol (3,5,4'-trihydroxy-trans-stilbene) is a non-flavonoid polyphenol that may be present in a limited number of foodstuffs such as grapes and red wine. Resveratrol has been reported to exert a plethora of health benefits through many different mechanisms of action. This versatility and presence in the human di...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/13816128113199990407

    authors: Tomé-Carneiro J,Larrosa M,González-Sarrías A,Tomás-Barberán FA,García-Conesa MT,Espín JC

    更新日期:2013-01-01 00:00:00

  • Polymer Particulates in Drug Delivery.

    abstract::Development of effective drug delivery systems is important for medicine and healthcare. Polymer particulates (micro- and nanoparticles) have opened new opportunities in the field of drug delivery by overcoming various limitations of conventional delivery methods. The properties of polymeric particles can be readily t...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612822666160217125734

    authors: Kaur H,Kumar V,Kumar K,Rathor S,Kumari P,Singh J

    更新日期:2016-01-01 00:00:00

  • Can mycobacterial genomics generate novel targets as speed-breakers against the race for drug resistance.

    abstract::The rise of multi-drug resistant and extensively drug resistant M. tuberculosis around the world poses a great threat to human health, and necessitates development of new, effective and inexpensive anti-tubercular agents. The availability of knowledge on molecular biology of M. tuberculosis infection coupled with whol...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612819666131118165427

    authors: Chauhan RS,Chanumolu SK,Rout C,Shrivastava R

    更新日期:2014-01-01 00:00:00

  • Caenorhabditis elegans-based model systems for antifungal drug discovery.

    abstract::The substantial morbidity and mortality associated with invasive fungal infections constitute undisputed tokens of their severity. The continued expansion of susceptible population groups (such as immunocompromised individuals, patients undergoing extensive surgery, and those hospitalized with serious underlying disea...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161211795703753

    authors: Anastassopoulou CG,Fuchs BB,Mylonakis E

    更新日期:2011-01-01 00:00:00

  • Activated immune system and inflammation in healthy ageing: relevance for tryptophan and neopterin metabolism.

    abstract::Immune activation not only accompanies inflammation in various disorders including infections, autoimmune syndromes and cancer, but it also represents a characteristic feature of ageing. Immune deviations which are most widely expressed in the elderly include increased neopterin production and tryptophan breakdown. Th...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612820666140317110217

    authors: Capuron L,Geisler S,Kurz K,Leblhuber F,Sperner-Unterweger B,Fuchs D

    更新日期:2014-01-01 00:00:00

  • Antimicrobial peptides and peptaibols, substitutes for conventional antibiotics.

    abstract::In this review, the antimicrobial properties of a number of peptides are described. We first deal with helical linear peptides such as the well-known gramicidin, magainins, melittin, and other less well-known or more recently discovered peptides. Then, beta-sheet peptides (defensins isolated from insects and also from...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161210793292500

    authors: Duclohier H

    更新日期:2010-01-01 00:00:00

  • Nitric oxide in asthma therapy.

    abstract::The discovery of the delicate role of endogenous nitric oxide in the homeostasis of various cellular functions and the dynamic behaviour of the airways, has led to a new, rapidly progressing area of physiological science, that has direct bearing for our understanding of multiple airway diseases. The potentially protec...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/138161206778194141

    authors: Folkerts G,Nijkamp FP

    更新日期:2006-01-01 00:00:00

  • The role of niacin in lipid-lowering treatment: are we aiming too high?

    abstract::The clinically most relevant medications for lipid management are the statins, which constitute in the majority of the cases the basis of any lipid-modulating therapy. However, other agents are often needed to either reduce low-density cholesterol to target levels and/or to treat residual serum lipoprotein abnormaliti...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612811319170017

    authors: Gouni-Berthold I,Berthold HK

    更新日期:2013-01-01 00:00:00

  • The clinical applications of curcumin: current state and the future.

    abstract::Curcumin is a natural polyphenol product derived from the rhizome of the Curcuma longa. In vivo and in vitro studies have uncovered many important bioactivities of curcumin, such as antioxidant activity, inducing cell apoptosis, inhibiting cell proliferation, anti-cell adhesion and motility, anti-angiogenesis and anti...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:

    authors: Fan X,Zhang C,Liu DB,Yan J,Liang HP

    更新日期:2013-01-01 00:00:00

  • Colchicum Genus in the Writings of Ancient Greek and Byzantine Physicians.

    abstract::The plants of the Colchicum family were known during the archaic period in Greece for their deleterious properties. Later on, they were used for the treatment of podagra. The treatment was introduced by the ancient Greek physicians and passed on to the Byzantine and Arabian physicians to endure until nowadays. The fir...

    journal_title:Current pharmaceutical design

    pub_type: 历史文章,杂志文章,评审

    doi:10.2174/1381612824666180115111546

    authors: Tsoucalas G,Papaioannou T,Panayiotakopoulos G,Saridaki Z,Vrachatis DA,Karamanou M

    更新日期:2018-01-01 00:00:00

  • Good Practices in Forensic Toxicology.

    abstract::This manuscript provides an overview for analysts, medical and scientific investigators, and laboratory administrators, the range of factors that should be considered to implement best practice forensic toxicology. These include laboratory influence over the collection of specimens, their proper transport and chain-of...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612823666170704123836

    authors: Drummer OH

    更新日期:2017-01-01 00:00:00

  • Curcumin in combined cancer therapy.

    abstract::The mechanisms of beneficial preventive and therapeutic effects achieved by traditional and complementary medicine are currently being deciphered in molecular medicine. Curcumin, a yellow-colored polyphenol derived from the rhizome of turmeric (Curcuma longa), influences a wide variety of cellular processes through th...

    journal_title:Current pharmaceutical design

    pub_type: 杂志文章,评审

    doi:10.2174/1381612820666140826154601

    authors: Troselj KG,Kujundzic RN

    更新日期:2014-01-01 00:00:00